Easton Pharmaceuticals, Inc. (EAPH)

[lowe6er]

Easton Pharmaceuticals is committed to providing safe and effective products. Testing protocol is extensive for all products. Third party, multi-centre clinical trials will be completed for all products to validate efficacy statements and to give consumers confidence in the products.

ViorraTM has completed and passed irritation, allergic reaction, oral toxicity and three year stability studies. ViorraTM has completed an Open Label Clinical Pilot Trial to evaluate the safety and efficacy of the product. Pre and post-menopausal women with pre-diagnosed sexual function disorder for the past five years tested ViorraTM. There were no adverse data reported during the study and collectively the subjects reported: Less genital pain during intercourse, more sexual attempts with their partner, increase in vaginal lubrication, higher incidence of orgasm, increased desire to engage in sexual activity and an overall increase in sexual satisfaction.